| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| NSC-60339 |
2-氯-N1,N4-雙(4-(4,5-二氫-1H-咪唑-2-基)苯基)對苯二甲酰胺 |
70-09-7 |
詳細(xì)
|
| Nodakenin |
紫花前胡苷 |
495-31-8 |
詳細(xì)
|
| N-(Benzyloxycarbonyl)-D-serine-β-lactone |
(R)-(2-氧代-3-氧雜環(huán)丁基)氨基甲酸芐酯 |
98632-91-8 |
詳細(xì)
|
| NSC 31152 |
5-[(4-chlorophenyl)methylidene]-1,3-thiazolidine-2,4-dione |
24138-83-8 |
詳細(xì)
|
| NPD8733 |
化合物NPD8733 |
696655-62-6 |
詳細(xì)
|
| N-(2-Carboxybenzoyl)-(+)-10,2-camphorsultam |
N-(2-羧基苯甲酰)-(+)-10,2-樟腦磺內(nèi)酰胺 |
1820570-99-7 |
詳細(xì)
|
| NEO2734 |
化合物NEO2734 |
2081072-29-7 |
詳細(xì)
|
| Neopentylamine Hydroiodide |
2,2-二甲基丙-1-胺氫碘酸鹽 |
2733412-38-7 |
詳細(xì)
|
| N-Boc-PEG5-alcohol |
五聚乙二醇-叔丁氧羰基 |
1404111-67-6 |
詳細(xì)
|
| NSC228155 |
NSC228155 |
113104-25-9 |
詳細(xì)
|
| NIH-12848 |
化合物NIH12848 |
959551-10-1 |
詳細(xì)
|
| N-(9,9-Dimethyl-9H-fluoren-2-yl)-9,9-diphenyl-9H-fluoren-2-amine |
N-(9,9-二甲基-9H-芴-2-基)-9,9-二苯基芴-2-胺 |
1456702-56-9 |
詳細(xì)
|
| NCC007 |
NCC007游離態(tài) |
2342583-66-6 |
詳細(xì)
|
| Nardosinone |
甘松新酮 |
23720-80-1 |
詳細(xì)
|
| Nuzhenide |
特女貞苷 |
39011-92-2 |
詳細(xì)
|
| NS13001 |
N-(4-氯苯基)-2-(3,5-二甲基-1H-吡唑-1-基)-9-甲基-9H-嘌呤-6-胺 |
1063331-94-1 |
詳細(xì)
|
| NVP-CGM097 |
CS-1248 |
1313363-54-0 |
詳細(xì)
|
| NSC-703786 |
4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯胺 |
260443-89-8 |
詳細(xì)
|
| Navoximod |
1402837-78-8 |
1402837-78-8 |
詳細(xì)
|
| NSC12 |
CS-2161 |
102586-30-1 |
詳細(xì)
|
| Naporafenib |
LXH254 |
1800398-38-2 |
詳細(xì)
|
| NIK SMI1 |
NIK SMI1 |
1660114-31-7 |
詳細(xì)
|
| Norgestrel |
炔諾孕酮 |
6533-00-2 |
詳細(xì)
|
| N1,N3-Bis(2,2,6,6-tetramethylpiperidin-4-yl)isophthalamide |
N,N'-雙(2,2,6,6-四甲基-4-哌啶基)-1,3-苯二甲酰胺 |
42774-15-2 |
詳細(xì)
|
| NSC15364 |
1,3-二(4-氨基苯基)脲 |
4550-72-5 |
詳細(xì)
|
| Norisoboldine |
去甲異波爾定 |
23599-69-1 |
詳細(xì)
|
| Neticonazole Hydrochloride |
鹽酸奈替康唑 |
130773-02-3 |
詳細(xì)
|
| Neuropeptide W-23 (human) TFA |
TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU |
383415-79-0 |
詳細(xì)
|
| Nilotinib hydrochloride monohydrate |
鹽酸尼羅替尼一水合物 |
923288-90-8 |
詳細(xì)
|
| NMS-E973 |
NMS-E973 |
1253584-84-7 |
詳細(xì)
|
| N-Acetyl-O-phosphono-Tyr-Glu Dipentylamide TFA |
AC-TYR(PO3H2)-GLU-DIPENTYLAMIDE |
190078-50-3 |
詳細(xì)
|
| Nazartinib (EGF816) |
EGF816 |
1508250-71-2 |
詳細(xì)
|
| NSC 185058 |
N-(吡啶-2-基)吡啶-2-硫代甲酰胺 |
39122-38-8 |
詳細(xì)
|
| NGP 555 |
1304630-27-0 |
1304630-27-0 |
詳細(xì)
|
| NITD-349 |
1473450-62-2 |
1473450-62-2 |
詳細(xì)
|
| Noradrenaline bitartrate monohydrate |
L-去甲腎上腺素酒石酸鹽 一水合物 |
108341-18-0 |
詳細(xì)
|
| Neuropeptide FF TFA |
神經(jīng)肽-FF |
99566-27-5 |
詳細(xì)
|
| NCGC00378430 |
化合物NCGC00378430 |
920650-00-6 |
詳細(xì)
|
| Nortrachelogenin |
NORTRACHELOGENIN |
34444-37-6 |
詳細(xì)
|
| N-(6-Aminohexyl)maleimide Hydrochloride |
N-(6-氨基己基)馬來酰亞胺鹽酸鹽 |
75238-09-4 |
詳細(xì)
|
| NVP-TNKS656 |
NVP-TNKS656 |
1419949-20-4 |
詳細(xì)
|
| Nivolumab (anti-PD-1) |
納武單抗 |
946414-94-4 |
詳細(xì)
|
| NDMC101 |
化合物NDMC101 |
1308631-40-4 |
詳細(xì)
|
| NVR 3-778 |
4-fluoro-3-((4-hydroxypiperidin-1-yl)sulfonyl)-N-(3,4,5-trifluorophenyl)benzamide |
1445790-55-5 |
詳細(xì)
|
| NMS-P118 |
2-[1-(4,4-二氟環(huán)己基)-4-哌啶基]-6-氟-2,3-二氫-3-氧代-1H-異吲哚-4-甲酰胺 |
1262417-51-5 |
詳細(xì)
|
| N-(2-Acryloyloxyethyl)-N-benzyl-N,N-dimethylammonium Chloride |
丙烯酰氧乙基三甲基氯化銨 |
46830-22-2 |
詳細(xì)
|
| N-(tert-Butoxycarbonyl)-D-serine β-Lactone |
(R)-(2-氧代-3-氧雜環(huán)丁基)氨基甲酸叔丁酯 |
126330-77-6 |
詳細(xì)
|
| NVP-BVU972 |
6-[[6-(1-甲基-1H-吡唑-4-基)咪唑并[1,2-B]噠嗪-3-基]甲基]喹啉 |
1185763-69-2 |
詳細(xì)
|
| Niraparib (MK-4827) tosylate |
(3S)-3-[4-[7-(氨基羰基)-2H-吲唑-2-基]苯基]哌啶對甲苯磺酸鹽 |
1038915-73-9 |
詳細(xì)
|
| Naquotinib(ASP8273) |
NAQUOTINIB |
1448232-80-1 |
詳細(xì)
|
| NSC5844 (RE-640) |
N,N'-雙(7-氯-4-喹啉)-1,2-乙二胺 |
140926-75-6 |
詳細(xì)
|
| NSC 102533 |
4-hydroxy-3-phenyl-naphthalene-1,2-dione |
1150-59-0 |
詳細(xì)
|
| NP-G2-044 |
NP-G2-044 |
1807454-59-6 |
詳細(xì)
|
| Neticonazole |
奈康唑 |
130726-68-0 |
詳細(xì)
|
| Nodakenetin |
NODAKENETIN |
495-32-9 |
詳細(xì)
|
| Naringenin chalcone |
柚皮素查耳酮 |
73692-50-9 |
詳細(xì)
|
| Nemiralisib (GSK2269557) |
CS-2340 |
1254036-71-9 |
詳細(xì)
|
| NS1652 |
NS1652 |
1566-81-0 |
詳細(xì)
|
| NSAH |
化合物NSAH |
1099592-35-4 |
詳細(xì)
|
| N-Acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu TFA |
AC-TYR(PO3H2)-GLU-GLU-ILE-GLU-OH |
159439-02-8 |
詳細(xì)
|
| N-Chloroacetyl-D-phenylalanine |
N-氯乙酰-D-苯丙氨酸 |
137503-97-0 |
詳細(xì)
|
| NSC87877 |
8-羥基-7-[(6-磺基-2-萘基)偶氮基]-5-喹啉磺酸二鈉鹽 |
56932-43-5 |
詳細(xì)
|
| NAcM-OPT |
化合物NACM-OPT |
2089293-61-6 |
詳細(xì)
|
| N,N-Bis(4-bromophenyl)-[1,1':4',1''-terphenyl]-4-amine |
4',1'']terphenyl-4-yl-amine |
2205054-16-4 |
詳細(xì)
|
| Nylidrin Hydrochloride |
布芬寧鹽酸鹽 |
849-55-8 |
詳細(xì)
|
| NL-1 |
NL-1 |
188532-26-5 |
詳細(xì)
|
| N-Acetylornithine |
(S)-2-乙酰氨基-5-氨基戊酸 |
6205-08-9 |
詳細(xì)
|
| Naltrexone HCl |
鹽酸納曲酮 |
16676-29-2 |
詳細(xì)
|
| NSC 55655 |
5-[(2-nitrophenyl)methylidene]thiazolidine-2,4-dione |
36140-65-5 |
詳細(xì)
|
| Netupitant |
奈妥吡坦 |
290297-26-6 |
詳細(xì)
|
| NPS-1034 |
2-(4-氟苯基)-N-[3-氟-4-[(3-苯基-1H-吡咯并[2,3-B]吡啶-4-基)氧基]苯基]-2,3-二氫-1,5-二甲基-3-氧代-1H-吡唑-4-甲酰胺 |
1221713-92-3 |
詳細(xì)
|
| NT157 |
NT-157 |
1384426-12-3 |
詳細(xì)
|
| NCT-501 |
CS-2069 |
1802088-50-1 |
詳細(xì)
|
| N-(4-Bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine |
N-(4-溴苯基)-9,9-二甲基-9H-芴-2-胺 |
1644059-09-5 |
詳細(xì)
|
| NOD-IN-1 |
1-甲苯磺酰-1H-吲哚-2-甲酸乙酯 |
132819-92-2 |
詳細(xì)
|
| NSC 80538 |
NSC 80538;NSC-80538;NSC80538 |
370-26-3 |
詳細(xì)
|
| Nα-tert-Butoxycarbonyl-Nε-tetradecanoyl-L-lysine |
NΑ-叔丁氧羰基-NΕ-十四酰-L-賴氨酸 |
2173052-71-4 |
詳細(xì)
|
| N-[4-(tert-Butyl)phenyl]-9,9-dimethyl-9H-fluoren-2-amine |
N-(4-(叔丁基)苯基)-9,9-二甲基-9H-芴-2-胺 |
944418-46-6 |
詳細(xì)
|
| NE 52-QQ57 |
2-(4-((2-ethyl-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)methyl)phenyl)-5-(piperidin-4-yl)-1,3,4-oxadiazole |
1401728-56-0 |
詳細(xì)
|
| NG 52 |
2-[[6-[(3-氯苯基)氨基]-9-異丙基-9H-嘌呤-2-基]氨基]乙醇 |
212779-48-1 |
詳細(xì)
|
| NVS-ZP7-4 |
NVS-ZP7-4 |
2349367-89-9 |
詳細(xì)
|
| NHPI-PEG4-C2-NHS ester |
NHPI-PEG4-C2-NHS ESTER |
1415328-95-8 |
詳細(xì)
|
| NEDD8 inhibitor M22 |
化合物NAE-IN-M22 |
864420-54-2 |
詳細(xì)
|
| Navarixin (SCH-527123) |
3-[[3-[(二甲基氨基)羰基]-2-羥基苯基]氨基]-4-[[(R)-1-(5-甲基呋喃-2-基)丙基]氨基]-3-環(huán)丁烯-1,2-二酮 |
473727-83-2 |
詳細(xì)
|
| N-Allyl-N-tert-butylamine |
N-叔丁基丙烯基-1-胺 |
16486-68-3 |
詳細(xì)
|
| Nedisertib (M3814) |
NEDISERTIB |
1637542-33-6 |
詳細(xì)
|
| NMDAR antagonist 1 |
2,2,2-三氟-N-(丙-2-炔-1-基)乙酰胺 |
2220162-06-9 |
詳細(xì)
|
| NSC 31205 |
NSC31205;NSC-31205;NSC 31205 |
6320-51-0 |
詳細(xì)
|
| [Nphe1]Nociceptin(1-13)NH2 TFA |
Nphe1]Nociceptin(1-13)NH2 |
267234-08-2 |
詳細(xì)
|
| Nebivolol |
奈比洛爾 |
118457-14-0 |
詳細(xì)
|
| N6022 |
N6022 |
1208315-24-5 |
詳細(xì)
|
| Nilotinib hydrochloride |
尼羅替尼鹽酸鹽(無水) |
923288-95-3 |
詳細(xì)
|
| NSC-41589 |
化合物NSC-41589 |
6310-41-4 |
詳細(xì)
|
| Neuropeptide AF (human) TFA |
神經(jīng)肽AF（人類） |
192387-38-5 |
詳細(xì)
|
| NSC59984 |
1-(4-甲基-1-哌嗪基)-3-(5-硝基-2-呋喃基)-2-丙烯-1-酮 |
803647-40-7 |
詳細(xì)
|
| NVP-VID-400 |
N-(2-(1H-咪唑-1-基)-2-苯乙基)-4'-氯-[1,1'-聯(lián)苯]-4-甲酰胺 |
174262-13-6 |
詳細(xì)
|
| NSC45586 |
Benzoic acid,5-[2-[4-[2-(2,4-diamino-5-methylphenyl)diazenyl]phenyl]diazenyl]-2-hydroxy-,sodium salt (1:1) |
6300-44-3 |
詳細(xì)
|
| N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyloxirane-2-carboxamide |
N-[4-氰基-3-(三氟甲基)苯基]甲基環(huán)氧丙烯酰胺 |
90357-51-0 |
詳細(xì)
|
| NVP-BSK805 2HCl |
1942919-79-0 |
1942919-79-0 |
詳細(xì)
|
| Neurokinin B |
神經(jīng)激肽B TFA |
101536-55-4 |
詳細(xì)
|